Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
[Preprint]. 2020 Nov 18:2020.11.15.20229971.
doi: 10.1101/2020.11.15.20229971.

Genetic Liability to Cannabis Use Disorder and COVID-19 Hospitalization

Affiliations

Genetic Liability to Cannabis Use Disorder and COVID-19 Hospitalization

Alexander S Hatoum et al. medRxiv. .

Update in

Abstract

Behavioral and life style factors plausibly play a role in likelihood of being hospitalized for COVID-19. Genetic vulnerability to hospitalization after SARS-CoV2 infection may partially relate to comorbid behavioral risk factors, especially the use of combustible psychoactive substances. Paralleling the COVID-19 crisis has been increasingly permissive laws for recreational cannabis use. Cannabis Use Disorder (CUD) is a psychiatric disorder that is heritable and genetically correlated with respiratory disease, independent of tobacco smoking. By leveraging genome-wide association summary statistics of CUD and COVID-19, we find that at least 1/3 rd of the genetic vulnerability to COVID-19 overlaps with genomic liability to CUD (rg=.34, p=0.0003). Genetic causality as a potential mechanism of risk could not be excluded. The association between CUD and COVID-19 remained when accounting for genetics of trying marijuana, tobacco smoking (ever smoking regularly, cigarettes per day, smoking cessation, age of smoking initiation), BMI, fasting glucose, forced expiration volume, education attainment, and Townsend deprivation index. Heavy problematic cannabis use may increase chances of hospitalization due to COVID-19 respiratory complications. Curbing excessive cannabis use may be an essential strategy in COVID-19 mitigation.

PubMed Disclaimer

Conflict of interest statement

Competing Interest Statement: We have no financial interests to disclose.

Figures

Figure 1.
Figure 1.. Genetic associations between Substance Use Phenotypes and COVID-19 Hospitalization
A) Genetic correlations between COVID-19 hospitalization and inhalation substance use phenotypes. Cannabis Use Disorder (CUD) is highlighted in green. CPD = Cigarettes per day, Age Smoke = Age of first becoming a regular smoker, Ever Smoke = Ever being a regular smoker, Cannabis Use = Any lifetime cannabis use. (B) Heat map of genetic correlations between all phenotypes included in the study. COVID-19 Hosp = COVID-19 hospitalization (Variable COVIDB2 from the COVID Host Genomics Consortium(4)). TDI = Townsend Deprivation Index, COVID-19 Hosp. = COVID-19 hospitalization, Edu Attain = Education attainment, BMI = Body Mass Index. FEV1 = Forced Expiration Volume for 1 second, Fast Gluc = Fasting Glucose.

References

    1. Farhoudian A., et al., A global survey on changes in the supply, price and use of illicit drugs and alcohol, and related complications during the 2020 COVID-19 pandemic. medRxiv 13, 2020.07.16.20155341 (2020). - PMC - PubMed
    1. Hasin D. S., US Epidemiology of Cannabis Use and Associated Problems. Neuropsychopharmacology 43, 195–212 (2018). - PMC - PubMed
    1. Johnson E. C., et al., A large-scale genome-wide association study meta-analysis of cannabis use disorder. The Lancet Psychiatry 0 (2020). - PMC - PubMed
    1. , The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the COVID-19 virus pandemic. Eur. J. Hum. Genet. 28, 715–718 (2020). - PMC - PubMed
    1. Bulik-Sullivan B., et al., LD score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. (2015) 10.1038/ng.3211 - DOI - PMC - PubMed

Publication types